The objective of this study was to evaluate the effect of a PGF 2 a-analogue (PGF) on ovulation and pregnancy rates after timed artificial insemination (TAI) in cattle. In Experiment 1 cows received an intravaginal progesterone-releasing device (CIDR) plus 2 mg im of estradiol benzoate (EB) on Day 0. The CIDR devices were removed on Day 8, and all cows received 150 mg im of d-cloprostenol (PGF 2 aanalogue), 300 IU of eCG and 1 mg of estradiol cypionate (ECP) im. On Day 9, cows were randomly assigned into two groups: 1) ECP Group (n ¼ 17), that did not receive any further treatment; and 2) ECP-PG Group (n ¼ 14) that were given 150 mg of d-cloprostenol (PGF) as adjuvant stimulus for ovulation. No difference between groups was detected in interval for ovulation (P ¼ 0.5), and in the proportion of cows ovulating (P ¼ 0.09). In Experiment 2, multiparous suckling crossbred Aberdeen Angus cows (n ¼ 260), were treated into two groups, similarly as Experiment 1; ECP group (n ¼ 122), and ECP-PG group (n ¼ 138). All females were TAI on Day 10. The proportion of cows treated with ECP that became pregnant was 54.9% (67/122), and cows treated with ECP plus PGF was 55.1% (76/138; P ¼ 0.9). In Experiment 3, 686 Nelore cows, 40 to 50 days postpartum, were treated as Experiment 1 (ECP group), however, on Day 8 cows were divided into 3 groups: ECP Group (n ¼ 216); PGF-SC Group (n ¼ 228), in which cows did not receive ECP and were given an additional subcutaneous injection of PGF on Day 8; and PGFeIM Group (n ¼ 242), in which cows also did not receive ECP on Day 8 and were given an additional injection of PGF im on Day 9. On Day 10, estrus was evaluated at timed AI (TAI). There was no difference in the diameter of the dominant follicle at CIDR removal and at TAI, and pregnancy per AI among groups (P > 0.05). However, the proportion of cows that displayed estrus between CIDR removal and TAI was higher in ECP group than in PGF-SC and PGF-IM groups (P < 0.001). Cows that displayed estrus has higher P/AI than cows that did not (P ¼ 0.008). In conclusion, these results suggested that intramuscular or subcutaneous injection of PGF 2 a could be successfully used to induce ovulation in cattle undergoing TAI, with similar pregnancy rates when compared with ECP. The subcutaneous injection of PGF on the same day of CIDR removal could be an interesting alternative due it reduces cattle management to obtain similar results.
Introduction
Prostaglandins affect several pathways of reproduction, such as ovulation, luteal regression, the implantation and maintenance of pregnancy, parturition, and postpartum physiology [1] . The prostanoid prostaglandin F2a (PGF), derived from arachidonic acid, is a biologically potent substance with several applications in the control of reproduction. In cattle, the most common uses are estrus synchronization, regression of persistent CL, and induction of abortion or parturition [2] due to its luteolytic properties. PGF is widely used alone to induce luteolysis and estrus, however, PGF is also used associated to intravaginal progesterone device and estradiol esters in beef cows subjected to timed artificial insemination (TAI) protocols. Previously, intramuscular (im) injection of PGF has also been reported to act as an ovulatory stimulus in prepubertal heifers [3, 4] . These studies support the hypothesis that the PGF can induce ovulation of dominant follicle (DF) by an independent mechanism of luteolysis. More recently, im injection of PGF has been successfully used as an ovulation inducer in TAI protocols for beef [5] and dairy cows [6] .
In TAI programs, the effect of an extra im dose of PGF given 24 h after the progesterone device removal on hastening luteolysis has been studied [7e10] . Moreover, an extra im PGF injection was also given concurrently with AI [11, 12] . Authors suggest that this treatment may affect pregnancy per AI (P/AI) by increasing uterine contractility, thereby enhancing sperm transport. Although the effects of im PGF given at removal, 24 h later or at AI have been studied, to our knowledge, no study was performed to investigate the effect of im PGF as adjuvant for ovulation, or of subcutaneous (sc), as ovulatory stimulus in timed AI beef cows.
Although label indications for use in cattle recommended im injection of PGF, alternative routes have resulted in longer intervals from treatment to estrus [13] . The recommended dose (500 mg of cloprostenol) was equally efficacious when given either im or sc in inducing luteolysis, however sc via presented longer interval from injection to estrus [13, 14] .
The above mentioned considerations led us to believe that a sc via of PGF injection has similar effect on the P/AI in TAI programs as im via. We tested the hypotheses that an extra dose of PGF will induce more synchronized ovulations, and that the injection of sc PGF, given on CIDR removal, would provide similar P/AI as cows treated with im PGF, given 24 h after CIDR removal. The objectives of this study were to: 1) evaluate the ovulatory response and pregnancy of beef cows treated with an extra dose of PGF in conventional estradiol-progesterone based protocols, and 2) compare via of injection (sc vs. im) of PGF in beef cows subjected to TAI protocols.
Material and methods
The Committee for Ethics in Animal Experimentation from the Embrapa approved all of the procedures performed in the experiments described in this manuscript (Protocol F02.2014).
Experiment 1
This study was performed at the experimental research farm of Embrapa Rondônia (Brazilian Agricultural Research Corporation, Rondônia, Brazil; 08 0 48 0 12 00 S, 63 0 50 0 56 00 W).
Thirty one non lactating dual purpose crossbred cows (Gyr Â Holstein), 3e7 years old, 450e650 kg of body weight, and with a 3e4 of body condition score (BCS; range 1e5 where 1 ¼ emaciated and 5 ¼ obese; [15] ) were used. Cows were kept in an outdoor grazing system (Brachiaria brizantha pasture) with ad libitum access to mineral salt and water.
Cows at random stages of the estrous cycle, received an intravaginal progesterone-releasing device (1.9 g progesterone, CIDR In this experiment no AI procedures were performed and the status of the ovulatory follicle was followed by ultrasonography (SIUI CTS-900, equipped with a 5 MHz linear-array transducer (Guangdong, China)), at 12 h intervals from CIDR removal to ovulation. Ovulation was defined as the disappearance (from one scanning session to the next) of a previously identified follicle greater than or equal to 8 mm in diameter [16] .
Experiment 2
This trial was carried at a commercial farm located in the southern region of Brazil (32 0 20 0 46 00 S and 52 0 32 0 39 00 W).
Multiparous suckling crossbred Aberdeen Angus cows (n ¼ 260), 40 to 50 days postpartum with a body condition score (BCS) ranging from 2.5 to 3.5 (from 1 -emaciated to 5 -obese) were enrolled in this experiment. Cows were treated and separated into 2 groups, similarly as Experiment 1; ECP group (n ¼ 122), in which cows did not receive any further treatment after CIDR removal; and ECP-PG group (n ¼ 138), in which cows were given 150 mg of PGF on Day 9. All females were timed inseminated on Day 10.
Ultrasonic examinations were performed 30 days post-TAI to assess pregnancy status. Visualization of the embryonic vesicle and detection of the embryo were the positive criteria for determining pregnancy.
Experiment 3
The trial was carried in two commercial farms in center west region of Brazil (19 0 59 0 59.57 00 S and 55 0 3 0 6.05 00 W). The animals were kept in a grazing system (Brachiaria brizantha) with ad libitum access to mineral salt and water. For this experiment, 686 Nelore cows, 40 to 50 days postpartum with a body condition score (BCS) ranging from 2.5 to 3.5 were enrolled. Animals were treated as Experiment 1, however, on Day 8 cows were divided into 3 groups: ECP Group (n ¼ 216); PGF-SC Group (n ¼ 228), in which cows received an additional subcutaneous (in the neck region) injection of PGF on Day 8; and PGFeIM Group (n ¼ 242), in which cows received an additional injection of PGF im on Day 9. The PGF-SC and PGF-IM groups did not receive ECP at CIDR removal. On Day 8, cows were painted with chalk marker in the sacrocaudal region to identify cows that displayed estrus. On Day 10, estrus was evaluated at TAI, and deemed to have occurred in cows without a tail-head chalk mark. Semen from two Aberdeen Angus and two Nellore bulls were used for TAI and was equally distributed among treatments.
Ultrasonic examinations were performed at CIDR removal and at TAI in a subset (n ¼ 150), to measure the diameter of the largest DF, and 30 days post-TAI to assess pregnancy status in all cows.
Statistical analyses
All statistical analyses were performed using the SAS. The statistical model included the effect of treatment, bull, inseminator, BCS, lactation number, and days postpartum. The variables bull, inseminator, lactation number, and days postpartum had no significant effect on the model and were therefore excluded from it. Single-point outcome variables (e.g., time of ovulation, diameter of DF) were analyzed using analysis of variance (PROC GLIMMIX; SAS Inst. Inc., Cary, NC) and the means were compared among groups using Tukey's post hoc test.
Proportions with dichotomous outcomes (yes or no), such as ovulation, estrus detection and pregnancy rates (P/AI) were analyzed using the Chi-square test. The effect of BCS on the probabilities of P/AI were determined by Logistic regression using PROC LOGISTIC, and curves were created using the coefficients provided by the interactive data analysis from SAS and the formula y ¼ exp
The results are expressed as means ± SEM or as percentages. In all analyses, differences were considered significant when P 0.05, whereas 0.05 < P 0.10 was considered tendencies.
Results

Experiment 1
The ovarian responses of the Experiment 1 are summarized in Table 1 . No difference between groups was detected in diameter of the ovulatory follicle (P ¼ 0.9), in interval for ovulation (P ¼ 0.5), in the proportion of cows ovulating (P ¼ 0.09). All cows from ECP-PG group ovulated in a 12 h interval (10/10), while in the ECP group 83.3% (10/12) occurred in the same interval (P ¼ 0.48).
The distribution and percentage of heifers ovulating after CIDR removal is shown in Fig. 1. 
Experiment 2
No difference in the pregnancy per AI (P/AI) was detected between groups (P ¼ 0.9). Pregnancy per AI of cows treated with ECP was 54.9% (67/122), and cows treated with ECP plus PGF was 55.1% (76/138).
Experiment 3
Ovarian and estrus responses and pregnancy per AI of the Experiment 3 are summarized in Table 2 . There was no difference in the diameter of the DF at CIDR removal and at TAI. Similarly, the pregnancy per AI did not differ among groups (P > 0.05). However, the proportion of cows that displayed estrus between CIDR removal and TAI was higher in ECP group than in PGF-SC and PGF-IM groups (P < 0.001).
The overall occurrence of estrus was 41% (280/686). Cows that displayed estrus had a similar DF at CIDR removal (9.28 vs 8.85 mm, P ¼ 0.3) and larger DF at TAI (13.8 vs 12.7 mm, respectively; P ¼ 0.05) than cows that did not displayed estrus. Disregarding group, the P/AI of cows that displayed estrus was higher than cows that did not present (Table 3 ; P ¼ 0.05).
The BCS did not differ among groups (P > 0.05). However, the probability of pregnancy increased with the increasing BCS (P ¼ 0.018; Fig. 2 ).
Discussion
The results of the current study did not support the hypotheses tested. Although, the interval to ovulation and ovulation rate were not different between treatments in Experiment 1, all cows treated with an extra injection of PGF ovulated in a 12 h interval. This result led us to believe that PGF as adjuvant of ovulation could increase P/ AI in TAI programs. However, such synchrony in ovulations did not increase P/AI. Cows treated with sc PGF have similar P/AI of cows treated with im PGF or ECP. However, only the ECP group achieved P/AI (~50%) consistent with what others observed when using a conventional TAI procedure in early postpartum Nelore cows [17e19] .
Although the effect of injectable PGF on ovulation in beef cows has already been studied previously [5] , the mechanism of action remains unclear. Several studies have attempted to understand how PGF acts on inducing ovulation [20e22] . Previous reports have demonstrated an increase in LH pulse frequency occurring 6 h after treatment with a PGF analogue in anestrous cows [20] . In addition, it has been suggested that PGF2a exerts a direct effect on the anterior pituitary [1] , which increases pituitary responsiveness to GnRH and thereby enhances the release of LH [20] . PGF also appears to play a local role in the ovary. Prostaglandins (PGE2 and PGF2a) secreted by the granulosa cells [23, 24] was closely linked to the ovulatory process [25] . Our recent data, in which spayed cows were treated with 300 mg of PGF analogue (D-cloprostenol), 10.5 mg of GnRH analogue (Buserelin Acetate) or saline (0.9% of NaCl), demonstrated that only cows treated with GnRH had increasing of plasma LH concentration after treatment (not published data). Moreover, when PGF were used as ovulatory stimulus in dairy cows, it was observed an association between follicle vascularization and the time to ovulation [6] . This data led us to further hypothesize that PGF, acting mainly by a local mechanism, requires a higher developmental status of pre-ovulatory follicles compared to the systemic-mediated action of ECP. Even with this evidence, Table 1 Ovarian responses of cows treated with ECP or ECP plus Prostaglandin F2a (ECP-PG) to induce ovulation in Experiment 1. whether there is a direct action of exogenous PGF in the ovary remains unclear. Prostaglandin F 2a (PGF 2a ) is usually given by intramuscular (im) injection to induce luteolysis in cattle. Once PGF 2a is absorbed into the blood, it is almost completely inactivated (by oxidation) after passage through the lungs [26] . Numerous attempts have been made by others researchers to delay the absorption or reduce the metabolism of PGF 2a to prolong its action. When sc and im via of PGF injection were compared, im via resulted in shorter interval from treatment to estrus, and both via were equally efficient in the induction of luteolysis [13] . In our experiment, PGF sc at CIDR withdraw, reduces cattle management compared with im injection 24 h later, with similar results in P/AI. These findings are consistent with previous reports, in which PGF administered by iv [27] , ischiorectal fossa [14] , or behind the shoulder-sc injection [13] did not differ from im injection in luteolytic eficacy. Therefore, sc injection appears to be a viable route for the administration of dcloprostenol in cows submitted to TAI protocols with less cattle handling and, consequently, less stress.
It is well known that occurrence of estrus between the progesterone source removal and AI positively affect P/AI in TAI protocols. Disregarding treatment, in Experiment 3, cows that displayed estrus were more likely to become pregnant. Cows presenting estrus have larger follicular diameter at intravaginal device removal, larger follicular diameter at TAI, greater ovulation rate, increased subsequent luteal function, and greater P/AI than those that did not display estrus [28] . Moreover, BCS and estrus-cycling status have the greatest influence on the expression of estrus and pregnancy [29, 30] , as observed in the present experiment, in which cows with higher BCS presents higher pregnancy probability. Similar to the current results, it was reported that increasing BCS during the synchronization protocol enhanced the proportion of Nelore postpartum cows that displayed estrus after the estrus synchronization protocol [28] .
The effect of ECP in promoting estrus behaviour was reported previously [20] . When postpartum Nelore cows were induced to ovulate with ECP or GnRH in TAI programs, it was observed that ECP injection increased the proportion of cows displaying estrus after progesterone device removal. Expression of estrus is important, and stimulated by increasing concentrations of estradiol at a time when progesterone is low. The preovulatory secretion of estradiol by a DF coordinates a number of physiological processes required for the establishment of pregnancy. Some of these effects occur during the preovulatory period (e.g. estrus expression, induction of the gonadotropin surge that induces ovulation, and sperm transport). In our experiment, groups receiving PGF had less estrous expression compared with ECP; however, albeit not statistically significant, fewer pregnancies (~8%) were detected in PGF treated cows than ECP-treated cows.
One may question the use of dual-purpose (Bos indicus x Bos taurus) cows in Experiment 1, Bos taurus cows in Experiment 2 and Bos indicus in Experiment 3. However, as reported by Santos et al. (2001) [31] , several studies have observed that the diameter of POF and the time of ovulation of dual-purpose Girolando cows (Bos indicus x Bos Taurus) are similar to those observed for Bos taurus [32e34] and Bos indicus [17, 35] . Thus, it is assumed that the model used in Experiment 1 to determine the time of ovulation and ovulation rate was proper.
Conclusion
These results suggested that an extra injection of PGF did not increase pregnancy per AI in timed AI postpartum beef cows.
However, intramuscular or subcutaneous injection of PGF 2 a could be successfully used to induce ovulation in cattle undergoing TAI, with similar pregnancy rates when compared with ECP. Less corral management when subcutaneous injection of PGF at CIDR removal is used could be an effective alternative to TAI programs. Estrus-evaluate at TAI with aid of tail chalk. 
